216 related articles for article (PubMed ID: 19789535)
21. The potential use of saliva to detect recurrence of disease in women with breast carcinoma.
Bigler LR; Streckfus CF; Copeland L; Burns R; Dai X; Kuhn M; Martin P; Bigler SA
J Oral Pathol Med; 2002 Aug; 31(7):421-31. PubMed ID: 12165061
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic molecular markers in oral and lip squamous cell carcinoma--evaluation of expression and its significance].
Jaworska M; Kołosza Z; Liszka J; Nikiel B; Goleń M; Lange D; Scierski W; Namysłowski G
Otolaryngol Pol; 2008; 62(2):175-81. PubMed ID: 18637442
[TBL] [Abstract][Full Text] [Related]
23. Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy.
Grabenbauer GG; Mühlfriedel C; Rödel F; Niedobitek G; Hornung J; Rödel C; Martus P; Iro H; Kirchner T; Steininger H; Sauer R; Weidenbecher M; Distel L
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1041-50. PubMed ID: 11072161
[TBL] [Abstract][Full Text] [Related]
24. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
Bova RJ; Quinn DI; Nankervis JS; Cole IE; Sheridan BF; Jensen MJ; Morgan GJ; Hughes CJ; Sutherland RL
Clin Cancer Res; 1999 Oct; 5(10):2810-9. PubMed ID: 10537346
[TBL] [Abstract][Full Text] [Related]
25. Potential Salivary Proteomic Markers of Oral Squamous Cell Carcinoma.
Gallo C; Ciavarella D; Santarelli A; Ranieri E; Colella G; Lo Muzio L; Lo Russo L
Cancer Genomics Proteomics; 2016; 13(1):55-61. PubMed ID: 26708599
[TBL] [Abstract][Full Text] [Related]
26. Salivary microRNAs in oral cancer.
Zahran F; Ghalwash D; Shaker O; Al-Johani K; Scully C
Oral Dis; 2015 Sep; 21(6):739-47. PubMed ID: 25784212
[TBL] [Abstract][Full Text] [Related]
27. A comprehensive salivary analysis for oral cancer diagnosis.
Shpitzer T; Bahar G; Feinmesser R; Nagler RM
J Cancer Res Clin Oncol; 2007 Sep; 133(9):613-7. PubMed ID: 17479291
[TBL] [Abstract][Full Text] [Related]
28. Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma.
Vered M; Allon I; Dayan D
J Oral Pathol Med; 2009 Mar; 38(3):314-20. PubMed ID: 18783348
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D1 amplification in tongue and cheek squamous cell carcinoma.
Mahdey HM; Ramanathan A; Ismail SM; Abraham MT; Jamaluddin M; Zain RB
Asian Pac J Cancer Prev; 2011; 12(9):2199-204. PubMed ID: 22296356
[TBL] [Abstract][Full Text] [Related]
30. Relevance of serum and salivary sialic acid in oral cancer diagnostics.
Guruaribam VD; Sarumathi T
J Cancer Res Ther; 2020; 16(3):401-404. PubMed ID: 32719243
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic value of immunohistochemistry in salivary gland cancer].
Ettl T; Schwarz S; Kühnel T; Stockmann P; Reichert TE; Driemel O
HNO; 2008 Feb; 56(2):231-8. PubMed ID: 18214402
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic and prognostic ability of salivary MMP-9 for oral squamous cell carcinoma: A pre-/post-surgery case and matched control study.
Shin YJ; Vu H; Lee JH; Kim HD
PLoS One; 2021; 16(3):e0248167. PubMed ID: 33735248
[TBL] [Abstract][Full Text] [Related]
33. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
[TBL] [Abstract][Full Text] [Related]
34. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
[TBL] [Abstract][Full Text] [Related]
35. Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation.
Wang L; Liu T; Nishioka M; Aguirre RL; Win SS; Okada N
Oral Oncol; 2006 Jul; 42(6):625-31. PubMed ID: 16483832
[TBL] [Abstract][Full Text] [Related]
36. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma.
Wang Q; Gao P; Wang X; Duan Y
Clin Chim Acta; 2014 Jan; 427():79-85. PubMed ID: 24144867
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of proliferative and apoptotic markers in oral tongue squamous cell carcinomas.
Xie X; De Angelis P; Clausen OP; Boysen M
Oral Oncol; 1999 Sep; 35(5):502-9. PubMed ID: 10694951
[TBL] [Abstract][Full Text] [Related]
38. Molecular markers for predicting prostate cancer stage and survival.
Dunsmuir WD; Gillett CE; Meyer LC; Young MP; Corbishley C; Eeles RA; Kirby RS
BJU Int; 2000 Nov; 86(7):869-78. PubMed ID: 11069416
[TBL] [Abstract][Full Text] [Related]
39. Role of salivary biomarkers in early detection of oral squamous cell carcinoma.
Awasthi N
Indian J Pathol Microbiol; 2017; 60(4):464-468. PubMed ID: 29323056
[TBL] [Abstract][Full Text] [Related]
40. Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma in a Taiwanese Population.
Gleber-Netto FO; Yakob M; Li F; Feng Z; Dai J; Kao HK; Chang YL; Chang KP; Wong DT
Clin Cancer Res; 2016 Jul; 22(13):3340-7. PubMed ID: 26847061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]